Pramlintide improved glycaemic control and reduced weight in patients with type 2 diabetes treating to target with basal insulin

被引：0
|
作者：
Wilhelm, K. [1 ]
Riddle, M. [2 ]
Zhang, B. [1 ]
Maier, H. [1 ]
Kolterman, O. [1 ]
机构：
[1] Amylin Pharmaceut, San Diego, CA USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1011
引用
收藏
页码：S409 / S409
页数：1
相关论文
共 50 条
  • [41] Comment on: “Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes”
    Stephen Gough
    Drugs, 2019, 79 : 681 - 681
  • [42] Insulin glulisine imparts effective glycaemic control in patients with Type 2 diabetes
    Rayman, Gerrard
    Profozic, Velimir
    Middle, Michelle
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (02) : 304 - 312
  • [43] Sustained improvement of glycaemic control by insulin treatment in patients with type 2 diabetes
    Lindström, T
    DIABETOLOGIA, 1998, 41 : A248 - A248
  • [44] Correction to: Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes
    Sudesna Chatterjee
    Kamlesh Khunti
    Melanie J. Davies
    Drugs, 2019, 79 : 187 - 187
  • [45] Corrections to: Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes
    Sudesna Chatterjee
    Kamlesh Khunti
    Melanie J. Davies
    Drugs, 2019, 79 : 685 - 685
  • [46] Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes
    Donnelly, L. A.
    Morris, A. D.
    Evans, J. M. M.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2007, 100 (06) : 345 - 350
  • [47] Elucidating the role of weight loss and glycaemic control in patients with type 2 diabetes
    Sharma, Anukriti
    Mariam, Arshiya
    Zacherle, Emily
    Milinovich, Alex
    Bauman, Janine
    Sugano, David S.
    Noone, Josh
    Rajpura, Jigar R.
    Zimmerman, Robert S.
    Burguera, Bartolome
    Kattan, Michael W.
    Misra-Hebert, Anita D.
    Pantalone, Kevin M.
    Rotroff, Daniel M.
    DIABETES OBESITY & METABOLISM, 2024, 26 (11): : 5347 - 5357
  • [48] Pramlintide Improved Measures of Glycemic Control and Body Weight in Patients With Type 1 Diabetes Mellitus Undergoing Continuous Subcutaneous Insulin Infusion Therapy
    Herrmann, Kathrin
    Frias, Juan P.
    Edelman, Steven V.
    Lutz, Karen
    Shan, Kevin
    Chen, Steven
    Maggs, David
    Kolterman, Orville G.
    POSTGRADUATE MEDICINE, 2013, 125 (03) : 136 - 144
  • [49] Pramlintide, as an adjunct to long-acting insulin, led to improved A1C and body weight in patients with type 2 diabetes
    Lush, Cameron
    Strobel, Susan
    Zhang, Bei
    Frias, Juan
    DIABETES, 2006, 55 : A124 - A124
  • [50] Empagliflozin as add-on to basal insulin for 78 weeks improves glycaemic control with weight loss in insulin-treated type 2 diabetes mellitus
    Rosenstock, J.
    Jelaska, A.
    Wang, F.
    Kim, G.
    Broedl, U. C.
    Woerle, H. J.
    DIABETOLOGIA, 2013, 56 : S372 - S372
12345